Eletriptan HBr 40 mg Oral Tablet
RxNorm 359494
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 359494 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: eletriptan HBr 40 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Eletriptan 40 mg Oral Tablet
(Atom ID: 1563004)
PTPrescribable
Designated preferred name (PT):
Eletriptan (as eletriptan hydrobromide) 40 mg oral tablet
(Atom ID: 10297813)
SYPrescribable
Synonym (SY):
Eletriptan 40 mg (as eletriptan HBr 48.5 mg) Oral Tablet
(Atom ID: 9267543)
PSNPrescribable
Prescribable Name (PSN):
Eletriptan HBr 40 mg Oral Tablet
(Atom ID: 6368756)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely eletriptan (as eletriptan hydrobromide) 40 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10311907)
Patient Education
Eletriptan
Eletriptan is used to treat the symptoms of migraine headaches (severe throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Eletriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain, stopping pain signals from being sent to the brain, and blocking the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Eletriptan does not prevent migraine attacks or reduce the number of headaches you have.
[Learn More]
* Please review the disclaimer below.